Two Sigma Advisers’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.5K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $260K | Buy |
|
|||||
|
2024
Q2 | $366K | Buy |
|
|||||
|
2024
Q1 | $495K | Sell |
|
|||||
|
2023
Q4 | $780K | Buy |
|
|||||
|
2023
Q3 | $96.1K | Sell |
|
|||||
|
2023
Q2 | $300K | Sell |
|
|||||
|
2023
Q1 | $645K | Sell |
|
|||||
|
2022
Q4 | $1.72M | Buy |
|
|||||
|
2022
Q3 | $1.7M | Buy |
|
|||||
|
2022
Q2 | $734K | Buy |
|
|||||
|
2022
Q1 | $989K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $4.2M | Sell |
|
|||||
|
2020
Q1 | $5.83M | Sell |
|
|||||
|
2019
Q4 | $7.07M | Buy |
|
|||||
|
2019
Q3 | $5.25M | Buy |
|
|||||
|
2019
Q2 | $4.23M | Buy |
|
|||||
|
2019
Q1 | $550K | Buy |
|
|||||
|
2018
Q4 | $284K | Sell |
|
|||||
|
2018
Q3 | $711K | Buy |
|
|||||
|
2018
Q2 | $512K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $667K | Buy |
|
|||||
|
2016
Q3 | $284K | Buy |
|